NO952237D0 - Syntetiske katalytiske fri-radikal-oppfangere anvendelige som anti-oksidanter for forebyggelse og terapi av sykdom - Google Patents

Syntetiske katalytiske fri-radikal-oppfangere anvendelige som anti-oksidanter for forebyggelse og terapi av sykdom

Info

Publication number
NO952237D0
NO952237D0 NO952237A NO952237A NO952237D0 NO 952237 D0 NO952237 D0 NO 952237D0 NO 952237 A NO952237 A NO 952237A NO 952237 A NO952237 A NO 952237A NO 952237 D0 NO952237 D0 NO 952237D0
Authority
NO
Norway
Prior art keywords
antioxidants
therapy
free radical
radical scavengers
disease prevention
Prior art date
Application number
NO952237A
Other languages
English (en)
Other versions
NO319454B1 (no
NO952237L (no
Inventor
Bernard Malfroy-Camine
Michel Baudry
Original Assignee
Eukarion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eukarion Inc filed Critical Eukarion Inc
Publication of NO952237D0 publication Critical patent/NO952237D0/no
Publication of NO952237L publication Critical patent/NO952237L/no
Publication of NO319454B1 publication Critical patent/NO319454B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Hydrogenated Pyridines (AREA)
NO19952237A 1992-12-07 1995-06-06 Farmasoytiske preparater basert pa syntetiske katalytiske fri-radikal-oppfangere anvendelige som anti-oksidanter for forebyggelse og terapi av sykdom NO319454B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/987,474 US5403834A (en) 1992-12-07 1992-12-07 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
PCT/US1993/011857 WO1994013300A1 (en) 1992-12-07 1993-12-06 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease

Publications (3)

Publication Number Publication Date
NO952237D0 true NO952237D0 (no) 1995-06-06
NO952237L NO952237L (no) 1995-08-01
NO319454B1 NO319454B1 (no) 2005-08-15

Family

ID=25533292

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19952237A NO319454B1 (no) 1992-12-07 1995-06-06 Farmasoytiske preparater basert pa syntetiske katalytiske fri-radikal-oppfangere anvendelige som anti-oksidanter for forebyggelse og terapi av sykdom

Country Status (20)

Country Link
US (2) US5403834A (no)
EP (2) EP1642583A2 (no)
JP (1) JP3502099B2 (no)
KR (1) KR20040004386A (no)
AT (1) ATE290867T1 (no)
AU (1) AU697399B2 (no)
CA (1) CA2150937C (no)
CZ (1) CZ296288B6 (no)
DE (1) DE69333775T2 (no)
GB (2) GB2305107B (no)
HU (1) HU225109B1 (no)
LV (1) LV10924B (no)
NO (1) NO319454B1 (no)
NZ (1) NZ259200A (no)
OA (1) OA10165A (no)
PL (1) PL175446B1 (no)
RU (1) RU2157213C2 (no)
SK (1) SK74595A3 (no)
UA (1) UA27949C2 (no)
WO (1) WO1994013300A1 (no)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE36460E (en) * 1990-10-10 1999-12-21 Life Science Holdings, Inc. Method of providing circulation via lung expansion and deflation
US5653685A (en) * 1990-10-10 1997-08-05 Lrt, Inc. Method of providing circulation via lung expansion and deflation
US5403834A (en) * 1992-12-07 1995-04-04 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5696109A (en) * 1992-12-07 1997-12-09 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5834509A (en) * 1992-12-07 1998-11-10 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US7582786B2 (en) * 1992-12-07 2009-09-01 Eukarion Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5686436A (en) * 1993-05-13 1997-11-11 Hiv Diagnostics, Inc. Multi-faceted method to repress reproduction of latent viruses in humans and animals
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
JPH10500671A (ja) * 1994-05-13 1998-01-20 モンサント カンパニー ペルオキシ亜硝酸塩分解触媒の使用方法、そのための薬剤組成物
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
WO1996004311A1 (en) * 1994-08-03 1996-02-15 University Of Alabama At Birmingham Research Foundation Monoclonal antibody to nitrotyrosine, methods for diagnosis and methods for treatment of disease
US5900433A (en) * 1995-06-23 1999-05-04 Cormedics Corp. Vascular treatment method and apparatus
CA2247876A1 (en) * 1996-03-08 1997-09-12 Ronald M. Klatz Liquid ventilation method and apparatus
WO1998010057A1 (en) 1996-09-06 1998-03-12 Emory University Methods for testing compounds for use as therapeutic antioxidants
US6369106B1 (en) * 1996-12-26 2002-04-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment of ischemic brain injuries with brain targeted anti oxidant compounds
US6214817B1 (en) 1997-06-20 2001-04-10 Monsanto Company Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
US5834178C1 (en) * 1997-07-09 2002-04-23 Univ Wayne State Flush-storage solution for donor organs
US5829449A (en) * 1997-09-19 1998-11-03 Thione International, Inc. Smoking products containing antioxidants
AT409306B (de) * 1997-10-03 2002-07-25 Hoffmann La Roche Optisch chemischer sensor
DE69813898T2 (de) 1997-11-03 2004-03-11 Duke University Substituierte porphyrinen
CA2249778A1 (en) * 1997-12-15 1999-06-15 Bayer Corporation Competitive apo-peroxidase assay
GB9817845D0 (en) 1998-08-17 1998-10-14 Glaxo Group Ltd Chemical compounds
US7816403B2 (en) * 1998-09-08 2010-10-19 University Of Utah Research Foundation Method of inhibiting ATF/CREB and cancer cell growth and pharmaceutical compositions for same
US6703384B2 (en) * 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
MXPA01007451A (es) 1999-01-25 2004-03-10 Nat Jewish Med & Res Center Porfirinas sustituidas.
US6365385B1 (en) 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
US6303355B1 (en) 1999-03-22 2001-10-16 Duke University Method of culturing, cryopreserving and encapsulating pancreatic islet cells
US20040110722A1 (en) * 1999-05-27 2004-06-10 Ornberg Richard L. Modified hyaluronic acid polymers
AU5048400A (en) 1999-05-27 2000-12-18 Monsanto Company Biomaterials modified with superoxide dismutase mimics
US6179804B1 (en) * 1999-08-18 2001-01-30 Oxypatch, Llc Treatment apparatus for wounds
DE60132171D1 (de) * 2000-02-11 2008-02-14 Res Dev Foundation Tocopherole, tocotrienole, andere chrome und seitenketten-derivate und ihre verwendung
US20040047852A1 (en) * 2001-03-02 2004-03-11 Kennedy Thomas Preston Method of treating cancer
US20030069281A1 (en) * 2000-06-14 2003-04-10 Irwin Fridovich Tetrapyrroles
US6589948B1 (en) 2000-11-28 2003-07-08 Eukarion, Inc. Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
WO2002043514A1 (en) * 2000-11-28 2002-06-06 Lorillard Licensing Company, Llc A smoking article including a selective carbon monoxide pump
US6481442B1 (en) 2000-11-28 2002-11-19 Lorillard Licensing Company, Llc Smoking article including a filter for selectively removing carbonyls
US6692458B2 (en) * 2000-12-19 2004-02-17 Edwards Lifesciences Corporation Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis
ATE439134T1 (de) * 2001-01-19 2009-08-15 Nat Jewish Med & Res Center Medikament zum schutz in der radiotherapie
ITPI20010014A1 (it) * 2001-03-05 2002-09-05 Ivo Pera Composto per filtri per sigarette,o altri articoli da fumo,a base di sostanze antiossidanti ed il filtro cosi'ottenuto
KR100681326B1 (ko) * 2001-04-20 2007-02-15 주식회사 중외제약 신규한 망간-키랄성 화합물 및 그의 이용방법
WO2002098431A1 (en) * 2001-06-01 2002-12-12 National Jewish Medical And Research Center Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
WO2003010154A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. Seleno compounds containing nitrone moiety, their preparation and their therapeutic uses
WO2003010153A1 (en) * 2001-07-26 2003-02-06 Samsung Electronics Co. Ltd. N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
WO2003010143A1 (en) 2001-07-26 2003-02-06 Samsung Electronics Co., Ltd. Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
DK1463487T3 (da) * 2001-12-19 2010-08-23 Res Dev Foundation Liposomal afgivelse af vitamin-E baserede forbindelser
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
CA2488500A1 (en) * 2002-06-07 2003-12-18 Duke University Substituted porphyrins
US6835387B2 (en) * 2002-06-11 2004-12-28 Scimed Life Systems, Inc. Sustained release of superoxide dismutase mimics from implantable or insertable medical devices
US20040132789A1 (en) * 2002-08-22 2004-07-08 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
US20040044220A1 (en) * 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
SI1585548T1 (sl) 2002-12-09 2018-11-30 Abraxis Bioscience, Llc Sestave in metode odmerjanja farmakoloških sredstev
RU2361615C2 (ru) * 2002-12-09 2009-07-20 Абраксис Байосайенс, Ллс. Композиции и способы доставки фармакологических агентов
US7129035B2 (en) * 2002-12-11 2006-10-31 Cryolife, Inc. Method of preserving tissue
WO2005030137A2 (en) * 2003-09-24 2005-04-07 The University Of Toledo, A University Instrumentality Of The State Of Ohio Improving biomechanical performance of irradiated biological material
US20050100537A1 (en) * 2003-11-10 2005-05-12 Evans Gregory S. Methods and kits for reducing cellular damage, inhibiting free radical production, and scavenging free radicals in mammals
WO2006078713A2 (en) * 2005-01-19 2006-07-27 Metaphore Pharmaceuticals, Inc. Methotrexate combinations for treating inflammatory diseases
DE602006006995D1 (de) * 2005-05-04 2009-07-09 Coty Prestige Lancaster Group Verwendung von freien radikalfängern zum schutz und zur behandlung von durch chemotherapie verursachten haut- und haarschäden
EP2036550A4 (en) * 2006-06-28 2009-07-15 Ihi Corp MEDICAMENT, DRUG DELIVERY DEVICE, MAGNETIC DETECTOR, AND DRUG DESIGN METHOD
US8252780B2 (en) * 2006-12-01 2012-08-28 Women & Infants' Hospital Organometallic complexes as therapeutic agents
US20090169484A1 (en) 2007-12-28 2009-07-02 Ihi Corporation Iron-salen complex
RU2506083C2 (ru) 2008-05-23 2014-02-10 Нэшнл Джуиш Хелт Способ лечения поражений, ассоциированных с воздействием алкилирующих веществ
CN102239138A (zh) 2008-11-20 2011-11-09 株式会社Ihi 自磁性金属salen络合物
KR101050273B1 (ko) * 2008-11-21 2011-07-19 세종대학교산학협력단 살렌 전이금속 착화합물, 및 그 제조 방법
RU2533567C2 (ru) * 2010-04-06 2014-11-20 АйЭйчАй КОРПОРЕЙШН Производные комплекса металл-сален и способ их получения
CN102933216A (zh) * 2010-04-28 2013-02-13 株式会社Ihi 抗脑瘤药物
EP2578643B1 (en) * 2010-06-01 2019-07-10 IHI Corporation Fluorescent dye material and use thereof
SG192062A1 (en) * 2010-12-21 2013-08-30 Ihi Corp Metal-salen complex compound and production method for same
JP5873656B2 (ja) * 2011-06-13 2016-03-01 株式会社Ihi 金属サレン錯体化合物、局所麻酔薬剤及び抗悪性腫瘍薬剤
JP6017766B2 (ja) * 2011-07-26 2016-11-02 株式会社Ihi 新規な金属サレン錯体化合物の抗がん剤
SG11201401289YA (en) * 2011-10-04 2014-07-30 Ihi Corp Medicinal agent responsive to metal salen complex compound, and system for controlling in vivo behavior of metal salen complex compound
JP6046338B2 (ja) 2011-10-27 2016-12-14 株式会社Ihi ラジカル抑制剤
KR102086022B1 (ko) * 2012-01-05 2020-03-06 플레드파르마 에이비 칼망가포디피르, 신규 화학 물질 및 기타 혼합 금속 착물, 제조방법, 조성물 및 치료방법
CN108030926B (zh) * 2017-12-15 2021-07-13 武汉工程大学 一种具有高的SOD酶活性的Salen型锰配合物-壳聚糖复合材料及其制备方法
RU2699040C1 (ru) * 2018-07-23 2019-09-03 Федеральное государственное бюджетное учреждение науки "Уральский научно-практический центр радиационной медицины Федерального медико-биологического агентства" (ФГБУН УНПЦ РМ ФМБА России) Способ экстренной профилактики и лечения острой лучевой болезни (варианты)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US5106841A (en) * 1986-05-13 1992-04-21 Chai-Tech Corporation Antiviral compositions and method for their use
US5223538A (en) * 1987-03-31 1993-06-29 Duke University Superoxide dismutase mimic
AU678139B2 (en) * 1991-08-26 1997-05-22 Research Corporation Technologies, Inc. Method of enantio selectively epoxidizing cinnamate derivatives
US5403834A (en) * 1992-12-07 1995-04-04 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease

Also Published As

Publication number Publication date
GB2277873A (en) 1994-11-16
NO319454B1 (no) 2005-08-15
CZ296288B6 (cs) 2006-02-15
JP3502099B2 (ja) 2004-03-02
LV10924A (lv) 1995-12-20
ATE290867T1 (de) 2005-04-15
AU5741994A (en) 1994-07-04
HU9501644D0 (en) 1995-08-28
SK74595A3 (en) 1996-05-08
EP0746321A4 (en) 2001-05-09
NO952237L (no) 1995-08-01
PL309334A1 (en) 1995-10-02
EP0746321A1 (en) 1996-12-11
EP0746321B1 (en) 2005-03-16
GB2305107B (en) 1997-05-14
US5403834A (en) 1995-04-04
CA2150937C (en) 2007-08-14
JPH08504211A (ja) 1996-05-07
AU697399B2 (en) 1998-10-08
DE69333775D1 (de) 2005-04-21
CA2150937A1 (en) 1994-06-23
KR20040004386A (ko) 2004-01-13
WO1994013300A1 (en) 1994-06-23
DE69333775T2 (de) 2006-04-06
OA10165A (en) 1996-12-18
GB2277873B (en) 1997-05-14
GB9415050D0 (en) 1994-09-14
HUT72967A (en) 1996-06-28
LV10924B (en) 1996-10-20
GB9621087D0 (en) 1996-11-27
PL175446B1 (pl) 1998-12-31
NZ259200A (en) 1997-06-24
GB2305107A (en) 1997-04-02
RU2157213C2 (ru) 2000-10-10
CZ144295A3 (en) 1996-10-16
EP1642583A2 (en) 2006-04-05
UA27949C2 (uk) 2000-10-16
US5827880A (en) 1998-10-27
HU225109B1 (en) 2006-06-28

Similar Documents

Publication Publication Date Title
NO952237L (no) Syntetiske katalytiske fri-radikal-oppfangere anvendelige som anti-oksidanter for forebyggelse og terapi av sykdom
CA2223510A1 (en) Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
TW272940B (en) /
PT671910E (pt) Utilizacao de derivados de adamantano no fabrico de um medicamento para o tratamento do glaucoma
PT754176E (pt) Novos carbamatos e ureias como modificadores da resistencia a multiplas drogas
DE3883035D1 (de) Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
ES2153862T3 (es) Bisulfan de administracion parenteral para el tratamiento de enfermedades malignas.
ES2188582T3 (es) El uso de ranitidina-citrato de bismuto en combinacion con claritromicina o claritromicina y tetraciclina en la fabricacion de un medicamento para tratar trastornos gastrointestinales.
DE3875866T2 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
IE893618L (en) Lactamimides in the treatment of drug-resistant protozoal¹infections
EP0325129A3 (en) Disubstituted pyridines
DE3770766D1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
MX9301935A (es) Compuestos para el tratamiento de alteraciones neurodegenerativas.
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
IS4198A (is) Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða
GB9004348D0 (en) New use of catechol derivatives and their physiologically acceptable salts and esters
IL89901A (en) Strobilurine derivative
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
DE69431187T2 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
AU8548291A (en) Menthol derivative having spasmolytic activity
IT1244360B (it) Preparato di zinco idrossido per la terapia nell'uomo dell'ulcera gastrica e duodenale
DE69001988D1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.
YU104192A (sh) 2-(4-hidroksipiperiodino)-1-alkanol derivati
ITMI920878A1 (it) Composizioni farmaceutiche comprendenti derivati monosialogangliosidici atte al trattamento del danno al midollo spinale.
ITVR930047V0 (it) Letto per la terapia di fluidizzazione in particolare per il decupito o la cura di ustioni

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application